demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
interferon
inhaled interferon
IFN alpha
pegylated interferon-α2b Pandit Shashi Bhushan
interferon / TFF2 Fu
peginterferon Jagannathan
PNB001 Lattmann

0 studies excluded by filtering options 0